Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis.
Cagol A, Cortese R, Barakovic M, Schaedelin S, Ruberte E, Absinta M, Barkhof F, Calabrese M, Castellaro M, Ciccarelli O, Cocozza S, De Stefano N, Enzinger C, Filippi M, Jurynczyk M, Maggi P, Mahmoudi N, Messina S, Montalban X, Palace J, Pontillo G, Pröbstel AK, Rocca MA, Ropele S, Rovira À, Schoonheim MM, Sowa P, Strijbis E, Wattjes MP, Sormani MP, Kappos L, Granziera C; MAGNIMS Study Group. Cagol A, et al. Among authors: strijbis e. JAMA Neurol. 2024 Feb 1;81(2):143-153. doi: 10.1001/jamaneurol.2023.4737. JAMA Neurol. 2024. PMID: 38079177 Free PMC article.
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab.
Toorop AA, van Lierop ZYG, Strijbis EEM, Teunissen CE, Petzold A, Wattjes MP, Barkhof F, de Jong BA, van Kempen ZLE, Killestein J. Toorop AA, et al. Among authors: strijbis eem. Neurol Neuroimmunol Neuroinflamm. 2020 Oct 13;8(1):e904. doi: 10.1212/NXI.0000000000000904. Print 2021 Jan. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 33051344 Free PMC article.
Neurophysiological brain function predicts response to cognitive rehabilitation and mindfulness in multiple sclerosis: a randomized trial.
Nauta IM, Kessels RPC, Bertens D, Stam CJ, Strijbis EEM, Hillebrand A, Fasotti L, Uitdehaag BMJ, Hulst HE, Speckens AEM, Schoonheim MM, de Jong BA. Nauta IM, et al. Among authors: strijbis eem. J Neurol. 2024 Apr;271(4):1649-1662. doi: 10.1007/s00415-024-12183-w. Epub 2024 Jan 26. J Neurol. 2024. PMID: 38278979 Free PMC article. Clinical Trial.
Micro-diffusely abnormal white matter: An early multiple sclerosis lesion phase with intensified myelin blistering.
Luchicchi A, Muñoz-Gonzalez G, Halperin ST, Strijbis E, van Dijk LHM, Foutiadou C, Uriac F, Bouman PM, Schouten MAN, Plemel J, 't Hart BA, Geurts JJG, Schenk GJ. Luchicchi A, et al. Among authors: strijbis e. Ann Clin Transl Neurol. 2024 Apr;11(4):973-988. doi: 10.1002/acn3.52015. Epub 2024 Feb 29. Ann Clin Transl Neurol. 2024. PMID: 38425098 Free PMC article.
The role of CD56bright NK cells in neurodegenerative disorders.
Rodriguez-Mogeda C, van Ansenwoude CMJ, van der Molen L, Strijbis EMM, Mebius RE, de Vries HE. Rodriguez-Mogeda C, et al. Among authors: strijbis emm. J Neuroinflammation. 2024 Feb 13;21(1):48. doi: 10.1186/s12974-024-03040-8. J Neuroinflammation. 2024. PMID: 38350967 Free PMC article. Review.
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.
Mattiesing RM, Kramer E, Strijbis EM, Brouwer I, van Schijndel RA, Gentile G, Battaglini M, De Stefano N, Uitdehaag BM, Barkhof F, Vrenken H, Schoonheim MM. Mattiesing RM, et al. Among authors: strijbis em. Mult Scler. 2024 Jan;30(1):44-54. doi: 10.1177/13524585231212879. Epub 2023 Nov 29. Mult Scler. 2024. PMID: 38018502 Free PMC article.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
Toorop AA, van Lierop ZY, Gelissen LM, Hoitsma E, Zeinstra EM, van Rooij LC, van Munster CE, Vennegoor A, Mostert JP, Wokke BH, Kalkers NF, Hoogervorst EL, van Eijk JJ, Roosendaal CM, Kragt JJ, Eurelings M, van Genugten J, Nielsen J, Sinnige L, Kloosterziel ME, Arnoldus EP, van Dijk GW, Bouvy WH, Wessels MH, Boonkamp L, Strijbis EM, van Oosten BW, De Jong BA, Lissenberg-Witte BI, Barkhof F, Moraal B, Teunissen CE, Rispens T, Uitdehaag BM, Killestein J, van Kempen ZL. Toorop AA, et al. Among authors: strijbis em. J Neurol Neurosurg Psychiatry. 2024 Apr 12;95(5):392-400. doi: 10.1136/jnnp-2023-332119. J Neurol Neurosurg Psychiatry. 2024. PMID: 37963723 Clinical Trial.
83 results